Instadiagnostics

About:

Instadiagnostics Inc., is developing a rapid, quantitative, point-of-care (POC) diagnostic platform.

Website: http://www.instadiagnostics.com

Top Investors: National Science Foundation, Ben Franklin Technology Partners of Southeastern Pennsylvania, Centers for Disease Control and Prevention, National Institute of General Medical Science, Congressionally Directed Medical Research Programs

Description:

Instadiagnostics Inc. (IDI) is developing a rapid, quantitative, point-of-care (POC) diagnostic platform with the aim of bringing centralized laboratory testing to the patient’s bedside. This platform will allow for early diagnosis, and/or treatment monitoring of patients at the POC (primary care centers, community clinics, emergency departments, etc.) without requiring additional trips to have blood drawn, lengthy wait times for results or having to wait for diagnosis/follow up testing. IDI’s diagnostic platform aims to improve patient care/satisfaction, reduce the number of medical visits, and eventually reduce overall medical costs.